China Resources Boya Bio pharmaceutical Group Co Ltd (300294) — Cash Flow Reinvestment Rate
China Resources Boya Bio pharmaceutical Group Co Ltd (300294) has a Cash Flow Reinvestment Rate of 9.61x as of December 2025, reinvesting CN¥353.75 Million (capex CN¥122.46 Million plus investments CN¥-231.28 Million) from operating cash flow of CN¥36.82 Million. Check China Resources Boya Bio pharmaceutical cash flow quality index to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
China Resources Boya Bio pharmaceutical Group Co Ltd Cash Flow Reinvestment Rate (2009–2025)
Historical reinvestment intensity for China Resources Boya Bio pharmaceutical Group Co Ltd across 15 annual periods. Explore how much of China Resources Boya Bio pharmaceutical 's assets are long-term investments to see how much of total assets are deployed in long-term investments.
Annual Cash Flow Reinvestment Rate for China Resources Boya Bio pharmaceutical Group Co Ltd (2009–2025)
Year-by-year capital reinvestment analysis for China Resources Boya Bio pharmaceutical Group Co Ltd. For live market cap and broader valuation context, see 300294 company net worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 7.52x | CN¥877.77 Million | CN¥116.69 Million | CN¥535.31 Million | ▲ +78.3% |
| 2024 | 4.22x | CN¥1.26 Billion | CN¥299.78 Million | CN¥197.79 Million | ▲ +2560.5% |
| 2023 | 0.16x | CN¥101.75 Million | CN¥641.73 Million | CN¥87.50 Million | ▼ -85.2% |
| 2022 | 1.07x | CN¥638.41 Million | CN¥596.44 Million | CN¥138.41 Million | ▼ -44.0% |
| 2021 | 1.91x | CN¥2.57 Billion | CN¥1.35 Billion | CN¥68.12 Million | ▲ +819.1% |
| 2020 | 0.21x | CN¥149.53 Million | CN¥718.58 Million | CN¥142.51 Million | ▼ -96.5% |
| 2018 | 6.02x | CN¥210.15 Million | CN¥34.90 Million | CN¥113.90 Million | ▲ +198.6% |
| 2016 | 2.02x | CN¥400.80 Million | CN¥198.76 Million | CN¥300.09 Million | ▲ +14.3% |
| 2015 | 1.76x | CN¥259.36 Million | CN¥147.02 Million | CN¥159.37 Million | ▲ +349.0% |
| 2014 | 0.39x | CN¥47.89 Million | CN¥121.88 Million | CN¥47.89 Million | ▲ +6.4% |
| 2013 | 0.37x | CN¥32.90 Million | CN¥89.11 Million | CN¥32.90 Million | ▲ +39.5% |
| 2012 | 0.26x | CN¥24.45 Million | CN¥92.36 Million | CN¥24.45 Million | ▲ +18.1% |
| 2011 | 0.22x | CN¥18.27 Million | CN¥81.53 Million | CN¥18.27 Million | ▼ -84.9% |
| 2010 | 1.48x | CN¥36.65 Million | CN¥24.77 Million | CN¥36.65 Million | ▲ +38.6% |
| 2009 | 1.07x | CN¥55.40 Million | CN¥51.88 Million | CN¥55.40 Million | — |